Inventor
CHARLES R. CANTOR
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms24%
G01NInvestigating or analysing materials by determining their chemical or physical properties24%
B01LChemical or physical laboratory apparatus for general use12%
G02BOptical elements, systems or apparatus12%
G06TImage data processing or generation, in general12%
C07KPeptides6%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology6%
Y02ATechnologies for adaptation to climate change6%
PatentTitleYear
12,534,758Methods and processes for non-invasive assessment of genetic variations202612,480,159Compositions containing identifier sequences on solid supports for nucleic acid sequence analysis202512,352,668Enhanced hydration methods and systems for histology202512,292,360Preliminary diagnoses of cut tissue sections202511,959,835Preliminary diagnoses of cut tissue sections202411,708,607Compositions containing identifier sequences on solid supports for nucleic acid sequence analysis202311,635,352Enhanced hydration methods and systems for histology202311,312,997Methods and processes for non-invasive assessment of genetic variations2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to SEQUENOM INC (4)· patent assignee history
2022–2026Based in US· patent location history
2023–2025Patents assigned to CLARAPATH INC (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CLARAPATH INC | 4 | 2023–2025 |
| SEQUENOM INC | 4 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2026 |